What if... international partnerships could help expand homegrown biotech companies?

CQDM (BL-NCE)

 

The CQDM research consortium recently partnered with Germany and Belgium as part of a Canada-Europe initiative to accelerate the development of new drugs and open new markets for homegrown biotechnology companies. Building on a successful five-year partnership with France, CQDM signed agreements with Germany and Belgium that will bring together academic researchers and small- and medium-sized enterprises (SMEs) from each country. Their goal: align scientific resources and expertise to develop next-generation tools, technologies and platforms that improve, enhance or accelerate drug developmentā€”a process that can take up to 15 years and cost more than $2 billion. Projects will receive up to $1 million from CQDM, the Central Innovation Program for SMEs of the German Federal Ministry for Economic Affairs and Energy (coordinated by AiF Projekt GmbH), and the Government of Wallonia and BioWin, the Health Cluster of Wallonia (Belgium).

For the last 10 years, Wallonia has been developing a smart specialization strategy via its Competitiveness Cluster policy. BioWin reflects our determination to strengthen the Walloon life sciences ecosystem on an international scale. Entering into this collaborative agreement with Canada provides us with the unique opportunity to bolster our economic trade in an innovative industry where both our countries rise together as world leaders, specifically in the health sector.Jean-Claude Marcourt, Vice President, Government of Wallonia; Minister of Economy, Industry, Innovation and Digital Technology
We are very pleased to expand our partnerships in Europe. These collaborations will allow academic researchers and SMEs across Canada to benefit from complementary expertise in Belgium and Germany while promoting the Canadian know-how abroad. Through these programs, researchers will develop long-term partnerships with their European counterparts while enjoying a privileged access to new markets.Diane Gosselin, President and CEO, CQDM